Toxin compounds with enhanced membrane translocation characteristics

Details for Australian Patent Application No. 2005310267 (hide)

Owner Allergan, Inc.

Inventors Aoki, Kei Roger; Fernandez-Salas, Ester; Lin, Wei-Jen; Sachs, George; Steward, Lance E.

Agent Davies Collison Cave

Pub. Number AU-A-2005310267

PCT Pub. Number WO2006/060044

Priority 10/909,769 02.08.04 US

Filing date 2 August 2005

Wipo publication date 8 June 2006

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/060044 Priority application(s): WO2006/060044

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005310269-Friction linear guide rail assembly for boiler tube cutting apparatus

2005310262-Supramolecular complexes as photocatylysts for the production of hydrogen from water